| Where is Kala Pharmaceuticals, Inc.'s corporate headquarters? |
| 100 Beaver Street, Suite 201 Waltham, MA 02453 |
| Where is Kala Pharmaceuticals, Inc. incorporated? |
| Delaware |
| When did Kala Pharmaceuticals, Inc. go public? What was the price? |
| Kala Pharmaceuticals went public on July 20, 2017 |
| What is Kala Pharmaceuticals, Inc.’s fiscal year? |
| December 31 |
| How is Kala Pharmaceuticals, Inc. stock traded? |
| Kala Pharmaceutical is traded on the NASDAQ Global Select Market under the symbol “KALA” |
| Does Kala Pharmaceuticals, Inc. pay dividends and have a dividend reinvestment program? |
| Currently, Kala Pharmaceuticals does not pay a dividend or offer a dividend reinvestment program |
| Who is Kala Pharmaceuticals, Inc.'s transfer agent? |
| American Stock Transfer & Trust Company, LLC. |
| How do I transfer stock, change the address on my shareholder account, or replace a lost stock certificate? |
| Please contact our transfer agent, American Stock Transfer & Trust Company, LLC, at http://www.astfinancial.com/issuer-investor-services. American Stock Transfer & Trust Company can look up your records and make any necessary adjustments. There may be a fee involved for replacing lost certificates. |
| Does Kala Pharmaceuticals, Inc. have a direct stock purchase plan? |
| Kala Pharmaceuticals does not offer a direct stock purchase plan |
| How can I purchase shares? |
| Shares can be purchased through a stockbroker of your choice. |
| Who is Kala Pharmaceuticals, Inc.'s auditor? |
| Deloitte & Touche |
| Who is Kala Pharmaceuticals, Inc.'s legal counsel? |
| Wilmer Cutler Pickering Hale and Dorr LLP, Boston, Massachusetts |
| How many employees does Kala Pharmaceuticals, Inc. have? |
| 42 full-time employees |
| Where can I get the latest corporate news releases? |
| You can view our recent press releases by visiting the Press Releases section of our website. |
| How can I sign up to receive Kala Pharmaceuticals’ press releases, email updates and other company information? |
| Please visit the Investors & Media section of our corporate website and choose the "Email Alerts" icon to be added to the Kala Pharmaceuticals distribution list |
| Whom should I contact regarding investor inquiries? |
| For investor related questions, please contact Michael Schaffzin at michael@sternir.com or via phone at +1-212-362-1200. |
| How can obtain a copy of your annual report and proxy? |
| SEC maintains an Internet website, which is located at http://www.sec.gov, that contains reports, proxy and information statements and other information regarding issuers that file electronically with the SEC. |